Sep 13, 2017 11:30 am UTC| Business
PARSIPPANY, N.J., Sept. 13, 2017 -- Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX), today announced a collaboration with Aetna, one of the nation’s leading diversified health care benefits companies, with the support of the...
Avadel Pharmaceuticals to Present at Upcoming Investor Conferences
Sep 13, 2017 11:30 am UTC| Business
DUBLIN, Ireland, Sept. 13, 2017 -- Avadel Pharmaceuticals plc (NASDAQ:AVDL), today announced that management will present at two upcoming investor conferences: The Ladenburg Thalmann 2017 Healthcare Conference on...
Ascendant Resources Launches Virtual Tour of the El Mochito Mine
Sep 13, 2017 11:30 am UTC| Business
TORONTO, Sept. 13, 2017 -- Ascendant Resources Inc. (TSX:ASND) (OTCQX:ASDRF) (FRA:2D9) ("Ascendant" or the "Company”) is pleased to announce the launch of its 360° virtual tour of the El Mochito Mine located in...
Sep 13, 2017 11:00 am UTC| Business
HAIFA, Israel, Sept. 13, 2017 -- Pluristem Therapeutics Inc. (NASDAQ:PSTI) (TASE:PSTI), a leading developer of placenta-based cell therapy products, announced today that the company has been issued two new patents by...
Sep 13, 2017 11:00 am UTC| Business
MILAN, Italy, Sept. 13, 2017 -- FibroGen, Inc. (NASDAQ:FGEN), a science-based biopharmaceutical company, announced today positive results from the company’s Phase 2b randomized, double-blind, placebo-controlled study...
Sep 13, 2017 11:00 am UTC| Business
EDINBURGH, United Kingdom, Sept. 13, 2017 -- NuCana plc announced the presentation of interim first-in-human data from a Phase 1 clinical study of NUC-3373, its ProTide transformation of the active anti-cancer...
Sep 13, 2017 11:00 am UTC| Business
Esomeprazole Strontium Delayed-Release (DR) Capsules 49.3 mg is an FDA-approved, proprietary, prescription proton pump inhibitor (PPI) indicated for adults for the treatment of gastroesophageal reflux disease (GERD) and...